PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT

BACKGROUND: Methylation of O-6-methylguanine-DNA-methyltransferase (MGMT) promotor causes gene silencing and has been associated with a favourable prognosis in patients with glioblastoma multiforme (GBM) receiving alkylating chemotherapy. However, analysis of MGMT promotor methylation is usually rep...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neuro Oncol
Main Authors: Siller, Sebastian, Lauseker, Michael, Giese, Armin, Tonn, Joerg-Christian, Niyazi, Karim-Maximilian, Thon, Niklas, Suchorska, Bogdana, Kreth, Friedrich-Wilhelm
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2019
נושאים:
Molecular Pathology and Classification - Adult and Pediatric
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847860/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.600
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים